← Back to Search

Orthopedic Implant

IM Implant for Pelvic Fracture

N/A
Recruiting
Research Sponsored by CurvaFix, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 months post-implantation
Awards & highlights

Study Summary

Prospective, single arm, post-market evaluation to evaluate the use and performance of the IM Implant in a post market setting.

Eligible Conditions
  • Pelvic Fracture
  • Acetabular Fracture

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 months post-implantation
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months post-implantation for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Secondary Surgical Interventions (SSIs)
Secondary outcome measures
Health Economics
Mobility
Pelvic Reduction Stability

Trial Design

1Treatment groups
Experimental Treatment
Group I: IM ImplantExperimental Treatment1 Intervention
Male and female patients who present with a pelvic ring and/or acetabular fracture that has recently undergone surgery to be fixed with a CurvaFix IM Implant.

Find a Location

Who is running the clinical trial?

CurvaFix, Inc.Lead Sponsor
Jennifer HebertStudy DirectorClin-Assist, LLC

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~59 spots leftby Apr 2025